Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1371 Novel orally active and high tissue penetrant small molecules targeting surface and intracellular PD-L1 signals for cancer immunotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.